NCT03074266View on ClinicalTrials.gov

Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older

UnknownOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

June 8, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Blood Coagulation Test
Interventions
DIAGNOSTIC_TEST

GEM Hemochron 100 ACT

Activated Clotting Time

Trial Locations (9)

20912

Accriva Study Site, Takoma Park

21215

Accriva Study Site, Baltimore

22042

Accriva Study Site, Falls Church

25304

Accriva Study Site, Charleston

27514

Accriva Study Site, Chapel Hill

80045

Accriva Study Site, Aurora

90033

Accriva Study Site, Los Angeles

95816

Accriva Study Site, Sacramento

08903

Accriva Study Site, New Brunswick

Sponsors
All Listed Sponsors
lead

Accriva Diagnostics

INDUSTRY

NCT03074266 - Clinical Performance of the Investigational GEM Hemochron® 100 in Populations Ages 18 Years and Older | Biotech Hunter | Biotech Hunter